- Home
- REAL vs PRQR Comparison
REAL vs PRQR Comparison
Compare REAL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- PRQR
- Stock Information
- Founded
- REAL 2011
- PRQR 2012
- Country
- REAL United States
- PRQR Netherlands
- Employees
- REAL N/A
- PRQR N/A
- Industry
- REAL Other Specialty Stores
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- REAL Consumer Discretionary
- PRQR Health Care
- Exchange
- REAL Nasdaq
- PRQR Nasdaq
- Market Cap
- REAL 641.9M
- PRQR 179.1M
- IPO Year
- REAL 2019
- PRQR 2014
- Fundamental
- Price
- REAL $5.29
- PRQR $2.35
- Analyst Decision
- REAL Buy
- PRQR Strong Buy
- Analyst Count
- REAL 5
- PRQR 8
- Target Price
- REAL $8.40
- PRQR $8.88
- AVG Volume (30 Days)
- REAL 2.7M
- PRQR 357.1K
- Earning Date
- REAL 08-05-2025
- PRQR 08-07-2025
- Dividend Yield
- REAL N/A
- PRQR N/A
- EPS Growth
- REAL N/A
- PRQR N/A
- EPS
- REAL N/A
- PRQR N/A
- Revenue
- REAL $616,717,000.00
- PRQR $21,212,711.00
- Revenue This Year
- REAL $11.70
- PRQR N/A
- Revenue Next Year
- REAL $10.10
- PRQR N/A
- P/E Ratio
- REAL N/A
- PRQR N/A
- Revenue Growth
- REAL 11.89
- PRQR 85.91
- 52 Week Low
- REAL $2.24
- PRQR $1.07
- 52 Week High
- REAL $11.38
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- REAL 50.82
- PRQR 66.90
- Support Level
- REAL $5.17
- PRQR $2.10
- Resistance Level
- REAL $5.56
- PRQR $2.18
- Average True Range (ATR)
- REAL 0.26
- PRQR 0.13
- MACD
- REAL 0.06
- PRQR 0.01
- Stochastic Oscillator
- REAL 69.01
- PRQR 56.92
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.